Ouster CTO granted 75,415 RSUs in equity award
Frichtl Mark reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Frichtl Mark reported acquisition or exercise transactions in this Form 4 filing.
Ouster, Inc. Chief Technology Officer Mark Frichtl received a grant of 75,415 restricted stock units of common stock as equity compensation. The RSUs vest in 12 equal quarterly installments beginning on March 11, 2026, contingent on his continued service. Following this award, he holds 712,297 shares of common stock directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 75,415 | $0.00 | $0.00 |
Footnotes (1)
- F1. Represents Ouster, Inc. (the "Company") restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. The RSUs vest as to 1/12 of the total number of RSUs on each quarterly anniversary of March 11, 2026, the vesting commencement date, subject to the reporting person's continued service through the applicable vesting date. The RSUs have no expiration date.
Key Figures
Key Terms
restricted stock units financial
RSUs financial
vesting commencement date financial
contingent right financial
continued service financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Ouster (OUST) report for Mark Frichtl?
How do the new RSUs for Ouster (OUST) CTO vest?
What does each Ouster (OUST) RSU granted to the CTO represent?
Was there a purchase price for the Ouster (OUST) RSUs granted to the CTO?
AI-generated analysis. How Rhea-AI works. Not financial advice.